Let's get Phase III funded!

What began as a bold vision in 2015 has become a powerful reality. Phase I of the mistletoe clinical trial, the first of its kind in the United States, is now complete, thanks to Believe Big and the unwavering support of this incredible community.

The results are deeply encouraging. The trial demonstrated that mistletoe is safe, identified a recommended dosage, and showed promising potential to improve patients’ quality of life. These outcomes were strong enough to advance the research forward, an important milestone in bringing mistletoe therapy closer to standard oncology care.

And now, because of you, Phase II is fully funded and ready to begin. We are filled with gratitude for every prayer, every gift, and every voice that helped make this possible. This is more than progress, it’s hope in action.

But the journey isn’t over.

Phase III is the critical next step, the one that can ultimately lead to widespread adoption and insurance coverage, making this therapy accessible to patients who need it most. And unlike conventional treatments backed by large pharmaceutical funding, this research continues to depend on a community that believes in something bigger.

Let’s keep the momentum going.
Let’s finish what we started.
Let’s get Phase III funded, together.

Mistletoe Clinical Trial - Phase III

Team Members